Cargando…
Should Antipyretics Be Used to Relieve Acute Adverse Events Related to COVID-19 Vaccines?
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American College of Chest Physicians. Published by Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862017/ https://www.ncbi.nlm.nih.gov/pubmed/33549598 http://dx.doi.org/10.1016/j.chest.2021.01.080 |
| _version_ | 1783647196639395840 |
|---|---|
| author | Etminan, Mahyar Sodhi, Mohit Ganjizadeh-Zavareh, Saeed |
| author_facet | Etminan, Mahyar Sodhi, Mohit Ganjizadeh-Zavareh, Saeed |
| author_sort | Etminan, Mahyar |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7862017 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | American College of Chest Physicians. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78620172021-02-05 Should Antipyretics Be Used to Relieve Acute Adverse Events Related to COVID-19 Vaccines? Etminan, Mahyar Sodhi, Mohit Ganjizadeh-Zavareh, Saeed Chest General Interest Commentary and Announcement American College of Chest Physicians. Published by Elsevier Inc. 2021-06 2021-02-05 /pmc/articles/PMC7862017/ /pubmed/33549598 http://dx.doi.org/10.1016/j.chest.2021.01.080 Text en © 2021 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | General Interest Commentary and Announcement Etminan, Mahyar Sodhi, Mohit Ganjizadeh-Zavareh, Saeed Should Antipyretics Be Used to Relieve Acute Adverse Events Related to COVID-19 Vaccines? |
| title | Should Antipyretics Be Used to Relieve Acute Adverse Events Related to COVID-19 Vaccines? |
| title_full | Should Antipyretics Be Used to Relieve Acute Adverse Events Related to COVID-19 Vaccines? |
| title_fullStr | Should Antipyretics Be Used to Relieve Acute Adverse Events Related to COVID-19 Vaccines? |
| title_full_unstemmed | Should Antipyretics Be Used to Relieve Acute Adverse Events Related to COVID-19 Vaccines? |
| title_short | Should Antipyretics Be Used to Relieve Acute Adverse Events Related to COVID-19 Vaccines? |
| title_sort | should antipyretics be used to relieve acute adverse events related to covid-19 vaccines? |
| topic | General Interest Commentary and Announcement |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862017/ https://www.ncbi.nlm.nih.gov/pubmed/33549598 http://dx.doi.org/10.1016/j.chest.2021.01.080 |
| work_keys_str_mv | AT etminanmahyar shouldantipyreticsbeusedtorelieveacuteadverseeventsrelatedtocovid19vaccines AT sodhimohit shouldantipyreticsbeusedtorelieveacuteadverseeventsrelatedtocovid19vaccines AT ganjizadehzavarehsaeed shouldantipyreticsbeusedtorelieveacuteadverseeventsrelatedtocovid19vaccines |